Ladprao General Hospital Public : Report on the Use of Proceeds from the Capital Increase as of June 30, 2022
July 26, 2022 at 08:32 pm
Share
Translation
LPH/SET/2022/011
July 25, 2022
Subject : Report on the Use of Proceeds from the Capital Increase as of June 30, 2022
To
: Director and Manager
The Stock Exchange of Thailand
Ref.
1. The Company's Board of Directors' Meeting No.3/2016, held on July 21, 2016
2. Report on the Change in Investment Plan for Ladprao Social Security Medical Center Project on
July 22, 2016
Ladprao General Hospital Public Company Limited ("LPH") would like to report the use of proceeds from the initial public offering, on October 16 and 19-21, 2015, of 200 million ordinary shares at Baht 5.00 each, totaling net proceeds of Baht 971.98 Million after deduction of underwriting and incentive fees and other related offering expenses and Change in Investment Plan as referred to above.
The utilization report for the period ended as of 30 June 2022 shown as follows:-
(Unit : Million Baht)
Objective of the capital increase
Net
Use of Proceeds
Balance
Proceeds
IPO- June 30,2022
1.
Investment in Ladprao Excellence Center
300.00
300
-
2
Investment in Elderly NursingCenter Project, and
307.00
-
307.00
newhospital project and/or investment in other hospitals'
common shares *
3.
Debt repayment
360.00
360.00
-
4.
Working Capital
4.98
4.98
-
Total
971.98
664.98
307.00
Please be informed accordingly.
Yours sincerely,
(Dr. Ungoon Chantanavanich)
Chief Executive Officer
Attachments
Original Link
Original Document
Permalink
Disclaimer
Ladprao General Hospital pcl published this content on 27 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2022 00:31:01 UTC.
Ladprao General Hospital Public Company Limited is a Thailand-based company, which is principally engaged in hospital business. The Company is engaged in a private hospital business in Bangkok on Ladprao Road by providing general medical treatment services and serving as a center for various medical specializations. It operates through two segments: Hospital, and Scientific Laboratory Testing & Research. The Hospital segment includes hospital services, health care centers, and service contracts with social security office. The Scientific Laboratory Testing & Research segment offers scientific analytical and diagnostic services for food and agricultural, pharmaceutical, environmental covering product analysis, calibration of instruments and inspections. Its subsidiaries include Ladprao Health and Medical Product Co., Ltd., Asia Medical and Agricultural Laboratory and Research Center Public Company Limited, Asia Business Management Center Co, Ltd., LP Medical Center Co., Ltd. and others.